Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-03-02 @ 4:22 PM
Study NCT ID:
NCT00814112
Status:
WITHDRAWN
Last Update Posted:
2024-03-15
First Post:
2008-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glycosaminoglycans During Septic Shock - a Temporal Study
Sponsor:
Region Skane
Organization:
Study Overview
Official Title:
GAGS - Glykosaminoglykaner Vid Sepsis
Status:
WITHDRAWN
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of personell
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GAGS
Brief Summary:
We have previously shown that the plasma level of glycosaminoglycans (GAG) in septic shock patients are elevated compared to controls. The purpose of this study is to investigate the temporal dynamic of the blood level of GAG in ten septic shock patients. In addition, to assess the kinetics of GAG during septic shock we examine the liver function by galactose elimination capacity as well as excreted urinary GAG.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: